Introduction of human papillomavirus vaccination in Nordic countries

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Introduction of human papillomavirus vaccination in Nordic countries. / Sander, Bente Braad; Rebolj, Matejka; Valentiner-Branth, Palle; Lynge, Elsebeth.

In: The Vaccine Quarterly, Vol. 30, No. 8, 2012, p. 1425-33.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Sander, BB, Rebolj, M, Valentiner-Branth, P & Lynge, E 2012, 'Introduction of human papillomavirus vaccination in Nordic countries', The Vaccine Quarterly, vol. 30, no. 8, pp. 1425-33. https://doi.org/10.1016/j.vaccine.2011.11.097

APA

Sander, B. B., Rebolj, M., Valentiner-Branth, P., & Lynge, E. (2012). Introduction of human papillomavirus vaccination in Nordic countries. The Vaccine Quarterly, 30(8), 1425-33. https://doi.org/10.1016/j.vaccine.2011.11.097

Vancouver

Sander BB, Rebolj M, Valentiner-Branth P, Lynge E. Introduction of human papillomavirus vaccination in Nordic countries. The Vaccine Quarterly. 2012;30(8):1425-33. https://doi.org/10.1016/j.vaccine.2011.11.097

Author

Sander, Bente Braad ; Rebolj, Matejka ; Valentiner-Branth, Palle ; Lynge, Elsebeth. / Introduction of human papillomavirus vaccination in Nordic countries. In: The Vaccine Quarterly. 2012 ; Vol. 30, No. 8. pp. 1425-33.

Bibtex

@article{1848dd090b004d42b850c0e212c18e24,
title = "Introduction of human papillomavirus vaccination in Nordic countries",
abstract = "Cervical screening has helped decrease the incidence of cervical cancer, but the disease remains a burden for women. Human Papillomavirus (HPV) vaccination is now a promising tool for control of cervical cancer. Nordic countries (Denmark, Finland, Greenland, Iceland, Norway and Sweden) are relatively wealthy with predominantly publicly paid health care systems. The aim of this paper was to provide an update of the current status of introduction of HPV vaccine into the childhood vaccination programs in this region.",
keywords = "Europe, Female, Humans, Incidence, Papillomavirus Infections, Papillomavirus Vaccines, Uterine Cervical Neoplasms, Vaccination",
author = "Sander, {Bente Braad} and Matejka Rebolj and Palle Valentiner-Branth and Elsebeth Lynge",
note = "Copyright {\textcopyright} 2011 Elsevier Ltd. All rights reserved.",
year = "2012",
doi = "10.1016/j.vaccine.2011.11.097",
language = "English",
volume = "30",
pages = "1425--33",
journal = "The Vaccine Quarterly",
issn = "1935-5653",
publisher = "Wolters Kluwer Health * PharmaSolutions Division",
number = "8",

}

RIS

TY - JOUR

T1 - Introduction of human papillomavirus vaccination in Nordic countries

AU - Sander, Bente Braad

AU - Rebolj, Matejka

AU - Valentiner-Branth, Palle

AU - Lynge, Elsebeth

N1 - Copyright © 2011 Elsevier Ltd. All rights reserved.

PY - 2012

Y1 - 2012

N2 - Cervical screening has helped decrease the incidence of cervical cancer, but the disease remains a burden for women. Human Papillomavirus (HPV) vaccination is now a promising tool for control of cervical cancer. Nordic countries (Denmark, Finland, Greenland, Iceland, Norway and Sweden) are relatively wealthy with predominantly publicly paid health care systems. The aim of this paper was to provide an update of the current status of introduction of HPV vaccine into the childhood vaccination programs in this region.

AB - Cervical screening has helped decrease the incidence of cervical cancer, but the disease remains a burden for women. Human Papillomavirus (HPV) vaccination is now a promising tool for control of cervical cancer. Nordic countries (Denmark, Finland, Greenland, Iceland, Norway and Sweden) are relatively wealthy with predominantly publicly paid health care systems. The aim of this paper was to provide an update of the current status of introduction of HPV vaccine into the childhood vaccination programs in this region.

KW - Europe

KW - Female

KW - Humans

KW - Incidence

KW - Papillomavirus Infections

KW - Papillomavirus Vaccines

KW - Uterine Cervical Neoplasms

KW - Vaccination

U2 - 10.1016/j.vaccine.2011.11.097

DO - 10.1016/j.vaccine.2011.11.097

M3 - Journal article

C2 - 22154773

VL - 30

SP - 1425

EP - 1433

JO - The Vaccine Quarterly

JF - The Vaccine Quarterly

SN - 1935-5653

IS - 8

ER -

ID: 38276397